
    
      Our prior efficacy trial found that COPES was not inferior to in-person CBT-CP and that
      participants attended, on average, a little over two more treatment weeks in COPES than
      in-person treatment, presumably due to the ease of in-home treatment attendance relative to
      in-person treatment.
    
  